Ohio Board of Pharmacy Publishes Updated Patient & Caregiver Numbers for July 2021

OHIO:  The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for July 2021.

These numbers include:

  • 331,273 Recommendations
  • 202,666 Registered patients
    • 14,039 Patients with Veteran Status
    • 15,550 Patients with Indigent Status
    • 866 Patients with a Terminal Diagnosis
  • 125,298 Patients with both an active registration and an active recommendation
  • 183,009 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 23,472 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.

Columbia Care Brings Scale To New York Cannabis Program Through Acquisition Of One Of The Largest Operating Greenhouse Sites On East Coast

New site expands Columbia Care’s cultivation and production footprint by approximately 1M square feet; offers flexibility to scale with increasing market demand; supports potential use for future social equity partnerships and adult-use sales

 

NEW YORK: Columbia Care Inc. announced today it has acquired a 34-acre cultivation site in eastern Long Island, New York. The Company’s first harvest and sales from this property for the state’s medical marijuana program is expected in Q4 2021, pending regulatory approvals.

The Long Island location offers supplemental cultivation and manufacturing capacity for Columbia Care’s existing Rochester facility that has served New York’s more than 120,000 medical cannabis patients since 2015, to meet the demand of a growing medical market, which, subject to regulatory approval, will include a number of newly approved additional form factors, including flower, in 2021. The new site also allows the Company to diversify its operations and open opportunities to create potential social equity business partnerships; a dedicated, federally-licensed global medical cannabis manufacturing and research hub in Rochester; and support the company’s entrance into the state’s adult-use program.

This facility currently has approximately 740,000 square feet of operational greenhouse space, which the Company plans to acquire upon phase two of the transaction, with 200,000 square feet of incremental grow capacity, situated perfectly for both retail distribution to Columbia Care’s three NYC and Long Island dispensaries and wholesale distribution to the most densely populated metropolitan area in the United States. The property’s infrastructure is fully developed for industrial scale and throughput and is currently used for growing ornamental flowers. Additionally, the existing owners have previously planted and successfully harvested industrial hemp on-site.

“As a company whose roots are in New York, it has been incredibly important that we build a scalable, vertically-integrated operation in the state that not only delivers the very best quality and prices to our patients and partners today, but also ensures that we can continue to deliver on our mission to New Yorkers through future legal cannabis programs. This is a commitment to our patients, communities, regulators, elected officials and social equity partners that we are here for the long term and intend to be the leaders who define cannabis in New York State – made in New York, by New Yorkers for New Yorkers,” said Nicholas Vita, CEO of Columbia Care. “We are eager to see New York’s regulated market emerge as one of the top global cannabis markets, with some market size estimates exceeding $5B by 2025 and more than 75,000 jobs created by 2027. We intend to continue to invest in opportunities that support this growth for all.”

Columbia Care will pay a total purchase price of $42.5M, which includes $15.0M in cash and $27.5M in Columbia Care stock. The initial payment of $30.0M has been made. The remaining $12.5M in stock payment will follow in August 2021 upon completion of the second phase of the transaction.

Ohio Board Of Pharmacy Updated Patient & Caregiver Numbers For December 2020

OHIO:  The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for December 2020. These numbers include:

  • 214,916 Recommendations
  • 160,228 Registered patients
    • 10,938 Patients with Veteran Status
    • 11,591 Patients with Indigent Status
    • 861 Patients with a Terminal Diagnosis
  • 139,458 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 18,211 Registered CaregiversFor the full list of program numbers, please visit the Program Update page.

WSLCB Looking For Panelists For Its First Deliberative Dialogue Sessions

Be a Panelist, Participant, or Listener

WASHINGTON:  Do you want to share your perspectives about cannabis quality assurance testing? Would you like to share your experiences with fellow licensees, consumers, and others? Would you like to be part of a different way of sharing information and gaining understanding?

If you answered “yes,” let us know!

WSLCB has been working on developing new cannabis product-testing rules. A public hearing on proposed rules was held on November 18, 2020. While we heard oral comment from many licensees, we would like to hear from everyone in the supply chain so we have a better understanding of the complete system – processors, producers, retailers, consumers, and others. And we want everyone in the supply chain to have an opportunity to hear the wide range of perspectives

We’d like to hear from everyone in the supply chain so we have a better understanding of the complete system – processors, producers, retailers, consumers, and others. And we want everyone in the supply chain to have an opportunity to hear the wide range of perspectives.

About the sessions

LCB’s Policy and Rules manager Kathy Hoffman will moderate three sessions with different panelists and topics. To get the conversation started the sessions begin with prepared questions for each panel, with time near the end for audience questions and participation (online of course). Our goal is to increase communication between consumers, licensees, labs, and the agency.

The three session dates and topics as follows:

  • January 28, 2020: Consumer Panel (4 -5 panelists)
  • February 4, 2020: Processor/Producer Panel (5-6 panelists)
  • February 11, 2020: Cannabis Testing Lab Panel (4 -5 panelists)

We want to make sure that each panel represents the rich diversity of our communities, license types, and growing practices. Can you help?

Please send the following information to rules@lcb.wa.gov, attention Kathy Hoffman by close of business (5PM) on TUESDAY, JANUARY 20, 2020:

  1. Your name
  2. Which of the three panels and dates you’d like to be considered for
  3. Your contact information (email and phone number)
  4. Tell us if you are a consumer, producer, processor, producer/processor, retailer or lab employee or owner
  5. If you are a processor, producer or processor/producer, tell us:
    • Your tier size (1, 2,or 3); whether you are an indoor or outdoor grower; and where you are located.
  6. Tell us three or four questions you’d like to ask others on your panel (for example, how do other producers sample? Or, when you purchase product, what are you looking for?)

We will be sending more information on the deliberative dialogue process, our panelist selection process, and other details.

Don’t miss out on this opportunity to offer your perspectives on an important topic – send your information to rules@lcb.wa.gov, type in the subject line “Attention Kathy Hoffman” today!!

IM Cannabis to Acquire Trichome In Landmark Transaction

Establishes Global Growth Platform & Leading Multi-Country Operator

CANADA / ISRAEL:  IM Cannabis Corp., a multi-country operator in the medical cannabis sector with operations in Israel and across Europe, and Trichome Financial Corp., announced that they have entered into a definitive agreement to combine their businesses into a global leader in adult-use recreational and medical cannabis pursuant to a plan of arrangement to be completed under the Business Corporations Act. Following completion of the Transaction, the Combined Company will maintain offices in Glil Yam, Israel and Toronto, Canada, and will operate under the IM Cannabis Corp. corporate name with common shares trading on the Canadian Securities Exchange under the ticker symbol “IMCC.” The Company remains on track to finalize its listing on the NASDAQ Capital Market in Q1 2021.

The Combined Company is expected to be a global cannabis production and distribution leader with increasing revenue in Israel and Germany’s medical cannabis markets under the IMC brand, and in Canada’s adult-use recreational market through Trichome’s wholly-owned subsidiary, Trichome JWC Acquisition Corp. The Combined Company is anticipated to benefit from each team’s cross-functional brand-building and distribution expertise, which is expected to enable the Combined Company to immediately begin planning for a roll-out of JWC products in Israel and the EU. Both management teams share a prudent operating philosophy that is grounded in finding low capital, high return projects, and a focus on free cash flow generation. Strategically, there is a common goal of continuing an aggressive, synergistic and accretive acquisition strategy in North America. With continued revenue growth in all operating regions expected throughout 2021 and by maintaining a disciplined and lean cost structure, the Combined Company is forecast to be adjusted EBITDA positive in 2021.

Trulieve Opens First Dispensary In Seffner, Florida

The new dispensary marks the Company’s 75th location nationwide

FLORIDA:  Trulieve Cannabis Corp., a leading and top-performing cannabis company based in the United States, announced today the opening of a brand-new Florida dispensary, the Company’s 75th nationwide. The new location marks the first dispensary to open in Seffner, bringing patients direct access to Florida’s largest and broadest assortment of medical cannabis products.

The new dispensary supports Trulieve’s goal of expanding and ensuring direct, reliable patient access to medical cannabis across its home state of Florida. It joins the Company’s 69 other dispensaries statewide, including several in nearby Tampa, Clearwater, and St. Petersburg.

“Access is important to us and has been a driving factor for our growth across Florida for years. Over the past few months, we’ve prioritized opening in cities and towns where access to medical marijuana was limited because we believe patients should have reliable and safe access to the medications they’ve come to rely on,” said Trulieve CEO Kim Rivers. “We’ve come a long way in four years and we’re excited to end the year strong with our 75th location nationwide and the first dispensary in Seffner.”

In honor of the Company’s brand-new dispensary, all patients — from those new to Trulieve to the dedicated Truliever community — will be eligible for a 25% in-store discount at the new Seffner dispensary on opening day. In line with policies adopted statewide, all visitors are required to wear masks for the duration of their dispensary visit. Additionally, only patients and their state-approved caregivers will be allowed inside the waiting room and dispensary at this time.

ANNOUNCING: Trulieve Seffner Grand Opening
WHERE: 801 W Martin Luther King Blvd., Seffner, Florida 33584
WHEN: Wednesday, December 30, 2020, at 9:00 a.m.

In stores and online, patients will find Florida’s largest selection of THC and CBD products, available in a variety of delivery methods, including edibles, smokable cannabis, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers home delivery statewide for patients and convenient in-store pickup at each of its 70 dispensaries in Florida.

To assist patients with ordering, Trulieve has made our entire catalog of products available for online ordering, with in-store pickup and statewide home delivery options available. In addition, patients can schedule a complimentary 30-minute virtual consultation with a Trulieve certified consultant to help navigate questions on products, devices, or to review their doctor’s recommendation.

Furthermore, to assist with CDC recommendations for social distancing and in compliance with additional company-enforced safety guidelines, several measures have been taken to ensure the health and well-being of employees and patients, including modifications to the layout of all stores, installation of plexiglass partitions and HEPA air filtration scrubbers in every dispensary, increasing access to masks and sanitizer throughout the store for staff and visitors, utilizing visual aids to direct traffic throughout the store, and increasing the frequency of deep cleanings for all dispensaries.

Trulieve is closely monitoring the coronavirus situation and will update store policies as needed to ensure the highest level of safety of our patients and staff. All updates will be shared directly on Trulieve’s website as they are enacted.

The Office of Medical Marijuana Use recently announced the registry had surpassed 450,000 registered medical marijuana patients with an active ID card, with Trulieve consistently selling approximately half of the state’s overall volume per the Florida Department of Health. To support the state’s rapidly growing patient base, there are more than 2,700 registered ordering physicians in the State of Florida.

Arizona: Special Meeting of the Mayor and City Council on November 10, 2020 to Discuss Proposition 207

The Willcox City Council will meet to discuss and direct marijuana ordinance following the passing of Proposition 207.

ARIZONA: Arizona residents voted on November 3rd, 2020 to pass Proposition 207, which legalized the possession and use of recreational marijuana for adults (age 21 years or older) in Arizona. Individuals were permitted to possess no more than one ounce of marijuana and grow up to six marijuana plants in their residences. The legislation also allowed any person convicted of certain crimes related to marijuana possession, consumption, and transportation to petition for the expungement of their criminal record starting on July 12, 2021.

Prop. 207 placed a 16 percent tax on marijuana sales, in addition to the existing transaction privilege tax and use tax. Revenue from the tax was divided between public programs such as community college districts, infrastructure, public safety, and public health organizations.

Through this legislation, local governments have the ability to ban marijuana facilities and testing centers and can control of aspects of licensing, regulation, and zoning.

The community is invited to attend the meeting on Tuesday, November 10th, at 3:30 PM in the City Council Chambers located at 300 W Rex Allen Drive, Willcox, AZ 85643.

Massachusetts Marijuana Retailers Surpass $1 Billion In Gross Sales

Milestone reached nearly two years after adult-use sales started in Massachusetts; progress continues to achieve industry goals

MASSACHUSETTS: Adult-use Marijuana Retailers in Massachusetts have now tallied more than $1 billion in gross sales, according to information reported in the state’s mandatory seed-to-sale tracking system, the Cannabis Control Commission announced Tuesday.

At close of business on Friday, October 30, aggregate data recorded in Metrc by 80 Marijuana Retailers operating statewide reached $1,000,521,905, coming nearly two years after the first two adult-use stores on the East Coast opened their doors November 20, 2018.

“This sales milestone represents licensees’ ability to successfully support a safe, accessible, and effective adult-use industry, and I am pleased the resulting tax benefits will have a significant impact on communities throughout the Commonwealth,” Commission Chairman Steven J. Hoffman said. “These numbers also speak to Commission licensing and enforcement staff working around the clock to make sure these businesses and their products comply with all of our regulations, especially the health and safety provisions. Each year, as this marketplace matures, the public will continue to see progress on state mandates and Commission objectives, including our commitment to equity, and the steps we have taken in 2020 are evidence of that.”

Source: Cannabis Control Commission’s Open Data Platform

Over the first year of adult-use sales, from November 2018 to November 2019, 33 Marijuana Retailers generated $393.7 million in gross sales, before licensees ultimately tallied $444.9 million for the full calendar year of 2019.

Since January 1, 2020, Marijuana Establishments have already surpassed those figures, generating $539 million in gross sales despite two months of closures as a result of the COVID-19 public health emergency in Massachusetts. During the pandemic, the Commission has implemented numerous protocols, including social distancing requirements, sanitation measures, and curbside service at licensed locations throughout the state that put first the health and safety of employees, patients, and consumers, while also supporting Marijuana Establishments’ ongoing operations. Read more at MassCannabisControl.com/COVID19.

Licensing, Agents, and Equity

Since Massachusetts’ first two Marijuana Retailers opened in 2018, 82 more have received notices from the Commission to commence operations statewide and are in the process of opening. Another 201 Marijuana Retailers with provisional or final license approval are completing the Commission’s inspection and compliance procedures towards that end.

In total, the Commission has licensed 688 Marijuana Establishments, including Cultivators, Product Manufacturers, Independent Testing Laboratories, Microbusinesses, and more. Currently, 40 Cultivators are open for business, with the capacity to grow up to a maximum of 1.26 million square feet of canopy in the Commonwealth.

The Commission is also in the process of finalizing changes to its adult-use regulations that will support home delivery of marijuana and marijuana products, after launching the initial license applications for adult-use Delivery-Only operators in May. To further the agency’s mission of ensuring industry participation by communities that have been disproportionately harmed by marijuana prohibition, the evolving Marijuana Courier and Marijuana Delivery Operator license types will be exclusively available to certified Economic Empowerment Applicants (EEAs) and Social Equity Program (SEP) Participants for a minimum of three years. So far, the Commission has issued two Delivery-Only—or Marijuana Courier—licenses to such applicants and pre-certified 47 more who are interested in offering delivery services in Massachusetts.

To date, two EEA licensees, two SEP licensees, and five Disadvantaged Business Enterprises (DBE) – or state-certified minority-, woman-, or veteran-owned companies – have opened. Additionally, the Commission has issued provisional licenses to 14 more EEAs, 21 more SEP Participants, and 87 DBEs that represent they have attended the state’s Supplier Diversity Office class and received expedited review from the Commission. Another four provisional licenses have gone to applicants who maintain both EEA status and participate in SEP, while seven more provisional licenses have gone to SEP Participants who are also DBE certified.

As of October, across all categories of licenses, the adult-use cannabis industry in Massachusetts consists of nearly 10,300 active Marijuana Establishment Agent registrations, up from 6,700 in November 2019. Of those, approximately 33 percent identify as female and 66 percent identify as male, while 74.2 percent of registered and proposed agents identify as White, 6.7 percent identify as Hispanic, Latino, or Spanish, and 5.9 percent identify as Black or African American.

This spring, the Commission’s first cohort of 143 SEP Participants received technical assistance and training across four teaching tracks. For the second cohort, 285 applicants qualified and now have access to technical assistance and training that started in July and continues through this winter. Participants who are approved for the program based on three criteria receive automatic program benefits, such as expedited application review by the Commission’s licensing team, certain fee waivers, and exclusive access to license types such as the Marijuana Courier and Marijuana Delivery Operator licenses.

Public Health, Safety, and Research

Throughout 2020, the Commission has continued to lead on initiatives that prioritize the public health and safety of Massachusetts residents and increase patient and consumer awareness. As part of its multimillion-dollar campaign, More About Marijuana, which has traditionally focused on responsible use and preventing youth access, the Commission has incorporated new educational materials about the dangers of home manufacturingCOVID-19 safety tips for cannabis consumers, and the risks of vaping, in response to statutory requirements and recent health emergencies.

The Commission issued three industrywide emergency orders over the past year in response to reported occurrences of e-cigarette, or vaping, product use-associated lung injury (EVALI) in the Commonwealth and across the nation. Staff also surveyed licensees to understand the ingredients and sources of additives used in licensed products, published multiple sets of testing results pertaining to regulated vapes—effectively clearing their use of Vitamin E acetate—and issued new packaging, labeling, and testing requirements, including the testing of finished vaping products to protect consumers against hazardous additives and contaminants. This summer, the Commission’s Second Amended Quarantine Order Applying to Vaporizer Products provided several options for licensees to address previously quarantined products manufactured prior to December 12, 2019:

  • Voluntarily disposing of vaporizer products;
  • Releasing vaporizer products from quarantine for sale if first retested or remediated; or
  • Repurposing quarantined vaporizer products into other marijuana products after reclaiming marijuana oil from the quarantined product.

The Commission continues to develop a product database that will enable law enforcement, state and local officials, such as school administrators, and parents, to determine whether products that may be illegally diverted into the hands of youth and/or the public came from a licensed source or the illicit market.

Finally, the Commission released five comprehensive research reports in the past year which focus on youth usagepreliminary industry assessmentthe impact of legalizationthe state of the data, and the effectiveness of the Commission’s public awareness campaign. Work is underway to conduct a baseline assessment of impacts to the healthcare system, adult-use cannabis behaviors, the utility in using public safety data to assess social equity provisions, legal and illicit market cannabis use behaviors, cannabis-related disciplinary actions in schools, as well as continuing the primary collected surveys included in the Marijuana Baseline Health Study.

Additional information about the Commission’s sales, licensing, and equity data is available by visiting MassCannabisControl.Com, by contacting the Commission by phone (774-415-0200) or email (Commission@CCCMass.Com), or following the agency on Facebook and Twitter.

OLCC Streamlining Marijuana License Applications

Temporary Rule Changes

OREGON:  On October 15, 2020, the Commission adopted temporary rules intended to provide relief to the industry and allowing OLCC greater flexibility in the processing of marijuana license applications. The main changes implemented in these temporary rules are:

  • Revising the definition of who needs to be identified as an “applicant” for the license, including raising the threshold from the 10% to 20% ownership.
  • Changing license application requirements, including reducing the amount of information and documentation which was previously required.
  • Modifying when OLCC may request fingerprints for a background check to once per license year, rather than specifically in conjunction with a renewal application.
  • Applicants can change the location of their proposed licensed premises prior to licensure, except for Producers who are prohibited by law from making that type of change until January 2022.
  • Changes to notification and pre-approval requirements when licensees make changes to business structures or financial interests (see below).
  • Simplified paperwork requirements for Producer propagation endorsement and medically designated canopy registration.

In the coming months, the Commission will go through a permanent rulemaking process to finalize the rules, making adjustments based on feedback from the industry and other stakeholders. Anyone wanting to provide comment or input on proposed rules should subscribe to OLCC’s email updates to stay apprised of the most recent activities, including dates and deadlines for public comment.

 

License Application Streamlining

In light of the current licensing backlog, Commission staff have been developing a comprehensive strategy to improve the processing time frame for all licensing actions. The agency believes that implementing the flexibility afforded by this temporary rule package and making internal process adjustments will significantly reduce the time it takes staff to evaluate each license application. The goal is to make the entire licensing process more efficient, timely, and predictable.

There are three main features that characterize the agency’s new streamlined approach to licensing:

  1. Collecting fewer documents as part of the license application.
  2. Relying on the applicant’s attestation that they have provided complete and accurate information.
  3. Giving the applicant the responsibility for knowing and understanding the laws and rules around marijuana licenses, and ensuring that their business will comply with those rules.

As part of the streamlining process, OLCC will ask applicants to complete updated paperwork which aligns with the temporary rule. We recognize that many applicants have already filled out and submitted paperwork for the license application, but the new set of paperwork is straightforward and will significantly reduce the time it takes OLCC staff to evaluate the license application.

Under the streamlined licensing process, a complete application will typically include:

  • An Application Packet for the appropriate license type. These forms have been streamlined to collect the minimum necessary amount of information. They also now include attestations that OLCC staff will rely on to be accurate when determining whether a license can be issued.
  • A Marijuana Applicant Questionnaire, along with an Individual History form for each individual who qualifies as an “applicant” for the license. The Applicant Questionnaire replaces all of the business structure forms that OLCC has historically collected. OLCC license investigators will no longer routinely collect detailed paperwork describing the structure and ownership of the business and analyze that information to determine which individuals and legal entities are “applicants.” Instead, it is the responsibility of the business to completely and accurately identify all “applicants.” The investigation process will not routinely consider other persons with a “financial interest,” although OLCC retains the authority to do so if necessary.
  • A map or sketch of the proposed premises and a floor plan for any indoor areas. New Premises Map Instructions are available that identify what information needs to be included on the map and floor plan. OLCC staff will rely on the applicant’s attestation that the map and floor plan(s) are complete and accurate.
  • A Land Use Compatibility Statement (LUCS). This requirement has not changed. An application must include this form, signed by the local government where the proposed premises is located, showing that the proposed license type is not a prohibited use at the proposed premises.

OLCC staff will continue to evaluate each applicant’s relevant criminal history and their record of compliance when previously licensed before issuing a license.

If an applicant has previously submitted fingerprints for a background check with another marijuana license application, OLCC staff will use the results of that license investigation rather than having the person submit new fingerprints. If an applicant has not previously submitted fingerprints, they will need to do so before the application is assigned to a license investigator.

OLCC will continue to contact applicants to confirm that they are prepared to complete the licensing process within 60 days before assigning them to a license investigator. As part of this contact, OLCC staff will provide instructions for applicants to submit fingerprints.  Do not submit fingerprints until you have received these instructions from OLCC staff.

The licensing timelines established in OAR 845-025-1135 still apply:

  • An applicant must complete the application process within 60 calendar days of being contacted by their license investigator.
    • If an applicant does not complete the process in 60 days and has not previously been in a “hold” status, the OLCC will un-assign the application and place it on hold until the Commission is able to reassign it; the reassignment will NOT take place until after other applications have been processed. Due to the volume of other license actions waiting to be processed, there could be a significant wait time before the OLCC reassigns the application.
    • If an applicant does not complete the process in 60 days and has previously been in a “hold” status, the application will be deemed incomplete and inactivated.

 

Curaleaf Announces New Branding For All Connecticut Dispensary Locations

Curaleaf Brand Coming to Recently Acquired Arrow Alternative Care and Grassroots Dispensaries in GrotonHartfordMilford and Stamford

MASSACHUSETTS: Curaleaf Holdings, Inc., a leading vertically integrated cannabis operator in the United States, announced new Curaleaf dispensary branding for all of the Company’s recently acquired Arrow Alternative Care and GR Companies, Inc. (“Grassroots”) dispensary locations in Connecticut. Curaleaf is the largest national retail dispensary brand in the U.S., and a premium mainstream cannabis brand available in 23 states as well as across a wide range of innovative products and form factors.

Joseph Lusardi, Chief Executive Officer of Curaleaf, said: “Building on our market leading position in Connecticut, we’re pleased to bring the Curaleaf branding to all four of our local medical cannabis dispensaries in the state. The rebranding of these locations directly aligns with our strategy of building strong, national brands that are renowned for high-quality products, backed by science, that deliver exceptional customer satisfaction.  With our Curaleaf brand in health and wellness, and our Select brand ranked as the #1 cannabis oil brand, we remain focused on providing our products directly to an expanding range of Connecticut patients. Overall, we are extremely proud to be active partners within these local communities and we look forward to building long-lasting relationships with them.”

Curaleaf began cultivating and processing medical cannabis in Connecticut in 2014. Today, Curaleaf is one of four licensed growers in Connecticut and operates a 60,000 square foot cultivation facility in Simsbury that provides high-quality cannabis products to over 9,000 patients statewide through its four dispensaries as well as wholesale channels.

In April of 2020, Curaleaf achieved vertical integration in Connecticut with the completion of its acquisition of Arrows’ dispensaries in Harford, Milford and Stamford, three of the largest Connecticut metro-areas. Under Curaleaf’s branding strategy, all three former Arrow dispensaries have been rebranded as Curaleaf dispensaries. Strategically placed in key metro areas, Arrow established itself as a market leader in Connecticut, operating three out of the 18 total dispensaries in the state. The Hartford dispensary opened in 2016, followed by Milford in 2017 and the Stamford store opening to customers in January of 2020. Additionally, in July of 2020, Curaleaf successfully completed the acquisition of Grassroots, including the Grassroots Herbology dispensary located in Groton, which has also been rebranded as a Curaleaf dispensary.

Curaleaf’s Connecticut dispensaries offers a broad range of flower, extracted oil and edible products manufactured to meet the highest product quality and regulatory compliance standards. Connecticut recently added as a qualifying medical condition Chronic Pain of at least six months duration associated with a specified underlying chronic condition refractory to other treatment intervention, which has the potential to significantly expand the size of the addressable market. In June of 2020, Curaleaf expanded its line of Select brand products into Connecticut with Select Elite Live cartridges available at local medical dispensaries across the state. Select, America’s #1 cannabis oil brand, can be found in 14 states including ArizonaCaliforniaColoradoConnecticutFloridaMarylandMichiganNevadaNew YorkOhioOklahomaOregonMassachusetts, and Maine. As a recognized industry leader, Select is committed to meeting high quality control standards and testing transparency as well as delivering a smooth, flavorful experience with all products formulated with strain-specific terpenes.

During the COVID-19 pandemic, Curaleaf dispensaries have been deemed an essential service in many states, including Connecticut. Curaleaf continues to serve patients and customers while implementing heightened safety and hygienic measures including increased cleaning protocols, social distancing, mobile pre-ordering, and curbside pickup for at-risk populations.

For additional information about Curaleaf’s Connecticut dispensaries please visit https://ct.curaleaf.com/